Patent intelligence · US
US 10105289
Biomimetic mineral based endodontic cement composition and uses thereof
Biomimetic mineral based endodontic cement composition and uses thereof
Patent details — US 10105289
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 23, 2018
- Expiration
- Oct 18, 2038
- Applicant
- Essential Dental Systems, Inc.
- Claims
- 21
- CPC classes
- A61K, A61K6/25, A61K6/52, A61K6/54
Quick answer
US 10105289 (Biomimetic mineral based endodontic cement composition and uses thereof) is held by Essential Dental Systems, Inc.. Status: granted. Granted Oct 23, 2018. Expires Oct 18, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Essential Dental Systems, Inc.
- Grant date
- Expiration
- Claims
- 21
- CPC classes
- A61K, A61K6/25, A61K6/52, A61K6/54, A61K6/69, A61K6/836
More from Essential Dental Systems, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 10105289?
US 10105289 (Biomimetic mineral based endodontic cement composition and uses thereof) is held by Essential Dental Systems, Inc.. Status: granted. Granted Oct 23, 2018. Expires Oct 18, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10105289?
Essential Dental Systems, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 10105289 expire?
Our index shows an expiration date of Oct 18, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.